These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38885222)

  • 1. Periodontal inflammation as a potential driver of HIV low level viremia.
    Stam AJ; Groenewegen H; Vissink A; Wensing AMJ; Nijhuis M; Bierman WFW
    PLoS One; 2024; 19(6):e0305641. PubMed ID: 38885222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy.
    Han J; Mu W; Zhao H; Hao Y; Song C; Zhou H; Sun X; Li G; Dai G; Zhang Y; Zhang F; Zeng H
    Int J Infect Dis; 2020 Feb; 91():210-217. PubMed ID: 31821891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era.
    Lara-Aguilar V; Llamas-Adán M; Brochado-Kith Ó; Crespo-Bermejo C; Grande-García S; Arca-Lafuente S; de Los Santos I; Prado C; Alía M; Sainz-Pinós C; Fernández-Rodríguez A; Martín-Carbonero L; Madrid R; Briz V
    J Biomed Sci; 2024 Aug; 31(1):80. PubMed ID: 39160510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
    Gaifer Z; Boulassel MR
    J Int Assoc Provid AIDS Care; 2020; 19():2325958220979817. PubMed ID: 33372823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.
    Bull ME; Mitchell C; Soria J; Styrchak S; Williams-Wietzikoski C; Legard J; McKernan-Mullin J; Kraft K; Onchiri F; Stern J; Holte S; Ryan KJ; Acosta EP; La Rosa A; Coombs RW; Ticona E; Frenkel LM
    AIDS; 2018 Jul; 32(11):1389-1401. PubMed ID: 29683841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution.
    Kauffman RC; Villalobos A; Bowen JH; Adamson L; Schinazi RF
    PLoS One; 2014; 9(2):e88258. PubMed ID: 24505452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.
    Taramasso L; Magnasco L; Bruzzone B; Caligiuri P; Bozzi G; Mora S; Balletto E; Tatarelli P; Giacomini M; Di Biagio A
    J Clin Virol; 2020 Feb; 123():104255. PubMed ID: 31927152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
    Elvstam O; Medstrand P; Jansson M; Isberg PE; Gisslén M; Björkman P
    HIV Med; 2019 Oct; 20(9):571-580. PubMed ID: 31148335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.
    Maggiolo F; Callegaro A; Cologni G; Bernardini C; Velenti D; Gregis G; Quinzan G; Soavi L; Iannotti N; Malfatto E; Leone S
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):473-82. PubMed ID: 22481602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
    Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
    BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
    Vardhanabhuti S; Taiwo B; Kuritzkes DR; Eron JJ; Bosch RJ
    Antivir Ther; 2015; 20(1):73-6. PubMed ID: 24699164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of CD4
    Chen J; He Y; Zhong H; Hu F; Li Y; Zhang Y; Zhang X; Lin W; Li Q; Xu F; Chen S; Zhang H; Cai W; Li L
    Virol Sin; 2023 Jun; 38(3):398-408. PubMed ID: 36907331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
    Elvstam O; Medstrand P; Yilmaz A; Isberg PE; Gisslén M; Björkman P
    PLoS One; 2017; 12(7):e0180761. PubMed ID: 28683128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
    Tobin NH; Learn GH; Holte SE; Wang Y; Melvin AJ; McKernan JL; Pawluk DM; Mohan KM; Lewis PF; Mullins JI; Frenkel LM
    J Virol; 2005 Aug; 79(15):9625-34. PubMed ID: 16014925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following detection of low level plasma HIV RNA in HIV-infected patients previously virologically suppressed on antiretroviral therapy: a retrospective observational study.
    Warren AM; Cheng AC; Watson K; Lewin SR; Hoy JF
    Sex Health; 2017 Jun; 14(3):238-243. PubMed ID: 28445685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
    Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
    HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.
    Falasca F; Di Carlo D; De Vito C; Bon I; d'Ettorre G; Fantauzzi A; Mezzaroma I; Fimiani C; Re MC; Vullo V; Antonelli G; Turriziani O
    BMC Infect Dis; 2017 Aug; 17(1):581. PubMed ID: 28830393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.
    Gonzalez-Serna A; Min JE; Woods C; Chan D; Lima VD; Montaner JS; Harrigan PR; Swenson LC
    Clin Infect Dis; 2014 Apr; 58(8):1165-73. PubMed ID: 24429436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.